With $450 million in facility-specific investment and at least 100 permanent operating jobs announced, this project clears both of AFT's qualifying thresholds ($100 million in facility-specific investment OR 100 permanent operating jobs). It is also confirmed by official public sources and involves a physical manufacturing facility in the United States.
View full methodology →The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
At a glance
- Company
- Eli Lilly
- Industry
- Pharmaceuticals
- Location
- Durham, North Carolina
- Investment
- $450.0M
- Permanent jobs announced
- At least 100
- Status
- Under Construction
- Announced
- Jan 24, 2023
- Expected opening
- 2027
- Added to tracker
- Sep 1, 2026
Official references
- Lilly's January 2023 additional $450 million Research Triangle Park investment announcement https://investor.lilly.com/news-releases/news-release-details/lilly-plans-invest-additional-450-million-manufacturing-site
- NCBiotech coverage of the $450M / 100-job RTP expansion https://www.ncbiotech.org/news/lilly-adds-450m-100-job-expansion-rtp-manufacturing-campus
Cite this project
American Factory Tracker. "Research Triangle Park Parenteral Filling and Device Assembly Expansion — Eli Lilly, Durham, NC." https://americanfactorytracker.com/projects/eli-lilly-research-triangle-park-expansion-2023. Accessed November 4, 2026.
Please also cite the original sources listed above for underlying figures.